IDYA
Price
$24.50
Change
-$0.33 (-1.33%)
Updated
Jul 25, 04:59 PM (EDT)
Capitalization
2.17B
18 days until earnings call
MGTX
Price
$8.37
Change
+$0.06 (+0.72%)
Updated
Jul 25, 04:59 PM (EDT)
Capitalization
667.84M
13 days until earnings call
Interact to see
Advertisement

IDYA vs MGTX

Header iconIDYA vs MGTX Comparison
Open Charts IDYA vs MGTXBanner chart's image
IDEAYA Biosciences
Price$24.50
Change-$0.33 (-1.33%)
Volume$5.48K
Capitalization2.17B
MeiraGTx Holdings
Price$8.37
Change+$0.06 (+0.72%)
Volume$5.53K
Capitalization667.84M
IDYA vs MGTX Comparison Chart in %
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. MGTX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a StrongBuy and MGTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (IDYA: $24.83 vs. MGTX: $8.31)
Brand notoriety: IDYA and MGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 194% vs. MGTX: 55%
Market capitalization -- IDYA: $2.17B vs. MGTX: $667.84M
IDYA [@Biotechnology] is valued at $2.17B. MGTX’s [@Biotechnology] market capitalization is $667.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileMGTX’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • MGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, MGTX is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 4 TA indicator(s) are bullish while MGTX’s TA Score has 3 bullish TA indicator(s).

  • IDYA’s TA Score: 4 bullish, 4 bearish.
  • MGTX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than MGTX.

Price Growth

IDYA (@Biotechnology) experienced а +12.40% price change this week, while MGTX (@Biotechnology) price change was -3.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.76%. For the same industry, the average monthly price growth was +19.76%, and the average quarterly price growth was +29.65%.

Reported Earning Dates

IDYA is expected to report earnings on Nov 11, 2025.

MGTX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+8.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($2.18B) has a higher market cap than MGTX($668M). MGTX YTD gains are higher at: 36.453 vs. IDYA (-3.385). MGTX has higher annual earnings (EBITDA): -141.78M vs. IDYA (-356.46M). IDYA has more cash in the bank: 693M vs. MGTX (66.5M). IDYA has less debt than MGTX: IDYA (26M) vs MGTX (80.9M). MGTX has higher revenues than IDYA: MGTX (34.5M) vs IDYA (7M).
IDYAMGTXIDYA / MGTX
Capitalization2.18B668M326%
EBITDA-356.46M-141.78M251%
Gain YTD-3.38536.453-9%
P/E RatioN/AN/A-
Revenue7M34.5M20%
Total Cash693M66.5M1,042%
Total Debt26M80.9M32%
FUNDAMENTALS RATINGS
IDYA vs MGTX: Fundamental Ratings
IDYA
MGTX
OUTLOOK RATING
1..100
1675
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
76
Overvalued
PROFIT vs RISK RATING
1..100
74100
SMR RATING
1..100
9499
PRICE GROWTH RATING
1..100
5338
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IDYA's Valuation (63) in the null industry is in the same range as MGTX (76) in the Biotechnology industry. This means that IDYA’s stock grew similarly to MGTX’s over the last 12 months.

IDYA's Profit vs Risk Rating (74) in the null industry is in the same range as MGTX (100) in the Biotechnology industry. This means that IDYA’s stock grew similarly to MGTX’s over the last 12 months.

IDYA's SMR Rating (94) in the null industry is in the same range as MGTX (99) in the Biotechnology industry. This means that IDYA’s stock grew similarly to MGTX’s over the last 12 months.

MGTX's Price Growth Rating (38) in the Biotechnology industry is in the same range as IDYA (53) in the null industry. This means that MGTX’s stock grew similarly to IDYA’s over the last 12 months.

MGTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as IDYA (100) in the null industry. This means that MGTX’s stock grew similarly to IDYA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDYAMGTX
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 16 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
77%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AINIX17.27N/A
N/A
Ariel International Institutional
MWEMX49.99N/A
N/A
MFS Global Equity R6
QMGIX13.03N/A
N/A
Invesco Advantage International R6
RMQHX611.22N/A
N/A
Rydex Monthly Rbl NASDAQ-100® 2x Strt H
FAEGX20.57N/A
N/A
Fidelity Advisor Equity Growth M

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with CGON. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+5.08%
CGON - IDYA
62%
Loosely correlated
-0.68%
IMNM - IDYA
61%
Loosely correlated
-1.83%
SYRE - IDYA
60%
Loosely correlated
-1.18%
NRIX - IDYA
60%
Loosely correlated
-0.86%
CRNX - IDYA
58%
Loosely correlated
-1.84%
More

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with IDYA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
-2.12%
IDYA - MGTX
51%
Loosely correlated
+5.08%
AURA - MGTX
50%
Loosely correlated
+0.86%
KRRO - MGTX
48%
Loosely correlated
-5.64%
RGNX - MGTX
47%
Loosely correlated
+0.44%
BEAM - MGTX
46%
Loosely correlated
-5.46%
More